Cargando…

SARS-CoV-2 infection in multiple sclerosis patients: interaction with treatments, adjuvant therapies, and vaccines against COVID-19

The SARS-CoV-2 pandemic has raised particular concern for people with Multiple Sclerosis, as these people are believed to be at increased risk of infection, especially those being treated with disease-modifying therapies. Therefore, the objective of this review was to describe how COVID-19 affects p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muñoz-Jurado, Ana, Escribano, Begoña M., Agüera, Eduardo, Caballero-Villarraso, Javier, Galván, Alberto, Túnez, Isaac
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253265/ https://www.ncbi.nlm.nih.gov/pubmed/35788744 http://dx.doi.org/10.1007/s00415-022-11237-1

Ejemplares similares

Melatonin and multiple sclerosis: antioxidant, anti-inflammatory and immunomodulator mechanism of action
por: Muñoz-Jurado, Ana, et al.
Publicado: (2022)

Impact of Repetitive Transcranial Magnetic Stimulation on Neurocognition and Oxidative Stress in Relapsing-Remitting Multiple Sclerosis: A Case Report
por: Agüera, Eduardo, et al.
Publicado: (2020)

Clinical and Neurochemical Effects of Transcranial Magnetic Stimulation (TMS) in Multiple Sclerosis: A Study Protocol for a Randomized Clinical Trial
por: Agüera, Eduardo, et al.
Publicado: (2020)

Extra-Virgin Olive Oil Modifies the Changes Induced in Non-Nervous Organs and Tissues by Experimental Autoimmune Encephalomyelitis Models
por: Conde, Cristina, et al.
Publicado: (2019)

An Entropy Approach to Multiple Sclerosis Identification
por: Perez, Gerardo Alfonso, et al.
Publicado: (2022)

Diagnostic Effectiveness of [(123)I]Ioflupane Single Photon Emission Computed Tomography (SPECT) in Multiple System Atrophy
por: Villena-Salinas, Javier, et al.
Publicado: (2023)

Follow-Up Findings in Multiple System Atrophy from [(123)I]Ioflupane Single-Photon Emission Computed Tomography (SPECT): A Prospective Study
por: Villena-Salinas, Javier, et al.
Publicado: (2023)

Impact of Light/Dark Cycle Patterns on Oxidative Stress in an Adriamycin-Induced Nephropathy Model in Rats
por: Escribano, Begoña M., et al.
Publicado: (2014)

Development of a High-Throughput Calcium Mobilization Assay for CCR6 Receptor Coupled to Hydrolase Activity Readout
por: Gómez-Melero, Sara, et al.
Publicado: (2022)

Neural Network Aided Detection of Huntington Disease
por: Alfonso Perez, Gerardo, et al.
Publicado: (2022)

CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases
por: Gómez-Melero, Sara, et al.
Publicado: (2023)

Transcranial Magnetic Stimulation Improves Muscle Involvement in Experimental Autoimmune Encephalomyelitis
por: Peña-Toledo, Maria Angeles, et al.
Publicado: (2021)

β-Glucans Could Be Adjuvants for SARS-CoV-2 Virus Vaccines (COVID-19)
por: Córdova-Martínez, Alfredo, et al.
Publicado: (2021)

Neutralizing antibody responses against SARS-CoV-2 in vaccinated people with multiple sclerosis
por: Gyang, Tirisham V., et al.
Publicado: (2022)

SARS-CoV-2 Infection and Risk Management in Multiple Sclerosis
por: Diaz de la Fe, Amado, et al.
Publicado: (2021)

Residual lesions on chest-Xray after SARS-CoV-2 pneumonia: Identification of risk factors()
por: Gómez Herrero, Helena, et al.
Publicado: (2022)

Multiple sclerosis following SARS-CoV-2 infection
por: Palao, M., et al.
Publicado: (2020)

SARS-CoV-2 triggered relapse of multiple sclerosis
por: Finsterer, Josef
Publicado: (2022)

Prevalence of Active Primitive Reflexes and Craniosacral Blocks in Apparently Healthy Children and Relationships with Neurodevelopment Disturbances
por: León-Bravo, Gema, et al.
Publicado: (2023)

Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?
por: Bellucci, Gianmarco, et al.
Publicado: (2021)

Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis
por: Woopen, Christina, et al.
Publicado: (2021)

SARS-CoV-2 infection and seroprevalence in patients with multiple sclerosis()
por: Piñar Morales, R., et al.
Publicado: (2021)

SARS-CoV-2 and Multiple Sclerosis: Potential for Disease Exacerbation
por: MacDougall, Madison, et al.
Publicado: (2022)

Lesiones residuales en radiografía simple de tórax tras neumonía por SARS-CoV-2: identificación de factores de riesgo
por: Gómez Herrero, Helena, et al.
Publicado: (2022)

SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry
por: Arrambide, Georgina, et al.
Publicado: (2021)

Guanidinoacetic Acid as a Nutritional Adjuvant to Multiple Sclerosis Therapy
por: Ostojic, Sergej M.
Publicado: (2022)

SARS-CoV-2 Vaccines and the Skin()
por: Galván-Casas, C., et al.
Publicado: (2021)

Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems
por: Shalash, Ahmed O., et al.
Publicado: (2022)

The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2021)

Multiple sclerosis treatment blunts SARS-CoV-2 antibody response
por: Lemprière, Sarah
Publicado: (2021)

Could SARS-CoV-2 herald a surge of multiple sclerosis?
por: Shalaby, Nevin Mohieldin, et al.
Publicado: (2021)

Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases
por: Nistri, Riccardo, et al.
Publicado: (2021)

Safety and humoral response rate of inactivated and mRNA vaccines against SARS-CoV-2 in patients with Multiple Sclerosis
por: Ciampi, Ethel, et al.
Publicado: (2022)

Safety of Vaccines against SARS-CoV-2 among Polish Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies
por: Czarnowska, Agata, et al.
Publicado: (2022)

HIV infection and multiple sclerosis: a case with unexpected “no evidence of disease activity” status
por: Labella, Fernando, et al.
Publicado: (2021)

Cross-reactivity of antibodies against interferon beta in multiple sclerosis patients and interference of the JAK-STAT signaling pathway
por: Hurtado-Guerrero, Isaac, et al.
Publicado: (2017)

Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain
por: Fernández, Oscar, et al.
Publicado: (2012)

Natalizumab safety in paediatric-onset multiple sclerosis at the time of SARS-Cov-2 pandemic
por: Margoni, Monica, et al.
Publicado: (2020)

Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg
por: Capasso, Nicola, et al.
Publicado: (2020)

Multiple Sclerosis and SARS-CoV-2 Vaccination: Considerations for Immune-Depleting Therapies
por: Sellner, Johann, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9icajk71v2qkh3aid16crp9b2f